Success rate and complications of endonasal dacryocystorhinostomy with unciformectomy
Jae Wook Yang
0
Ha Na Oh
0
0
This work was supported by the 2012 Inje University research grant
Background Endonasal dacryocystorhinostomy (DCR) has been widely used to treat nasolacrimal duct obstruction. Here, we evaluated the anatomical advantages of the uncinate process as a landmark and to study the effect of unciformectomy on success rate and complications of endonasal DCR . Methods In total, 288 eyes of 265 adult patients who underwent endonasal DCR between January 2003 and February 2010 were reviewed retrospectively. The eyes were classified into two groups, according to whether unciformectomy was performed or not. All surgical procedures and surgical indications were the same except unciformectomy and endonasal DCR was performed by one surgeon. Unciformectomy was performed by resecting the anterior part of uncinate process. Results One hundred and eighty-six eyes of 168 patients received endonasal DCR with unciformectomy, and 102 eyes of 97 patients received endonasal DCR alone. The average success rate of endonasal DCR with unciformectomy was There was no financial relationship in our study, and we have no conflict of interest. It has never been presented at any other conference. All authors have full control of all primary data, and agree to allow Graefe's Archive for Clinical and Experimental Ophthalmology to review our data.
-
97.8 % and that of endonasal DCR alone was 90.2 %, with
statistically significant difference (Student's t-test, p-value<
0.05). There were 14 eyes with post-operative nasolacrimal
obstruction, caused by granuloma in five eyes, intranasal
synechia in two eyes, membranous obstruction in six eyes,
and canalicular stenosis in one eye. There were no serious
complications such as orbital fat prolapse, cerebrospinal fluid
leak, or delayed hemorrhage.
Conclusions Anterior resection of the uncinate process
gives improved access to the lacrimal bone by exposing
the medial aspect of the lacrimal fossa and forming the
precise location of the osteotomy on the lacrimal bone
during endonasal DCR. Thus, the uncinate process can be
used as an anatomical landmark for endonasal DCR. The
unciformian endonasal DCR improves operation success
rate by allowing access to the large space of the nasal cavity
and reducing the synechiae of the nasal cavity.
DCR is commonly used to treat nasolacrimal duct obstruction.
It is a surgical method of making an ostium at the lacrimal
bone to form a shunt in the nasolacrimal pathway. During
most of the previous century, external DCR was standard
treatment for nasolacrimal duct obstruction because of its
intraoperative approach to the lacrimal sac and the high
success rate, whereas intranasal DCR has technical difficulties
visualizing the surgical site and achieving effective soft-tissue
and bone removal [1, 2]. However, since the development of
the rigid fiberoptic endoscope, endonasal DCR has been
widely used because it has significant advantages, including
the avoidance of scarring, minimal postoperative hematoma,
shorter postoperative recovery, preservation of the pumping
action on the orbicularis oculi muscle, and concurrent
correction of intranasal abnormalities, which can cause failure from
synechiae formation between the ostium and the septum or the
middle turbinate using the endoscope [36].
Despite these advantages, endonasal DCR has a number of
factors that can lead to failure. Anatomical variation in the
nasal cavity can cause difficulties for surgical correction.
Insufficient size of the osteotomy [6], cicatricial closure of
the ostium [79], adhesions between the ostium and the
middle turbinate [10], formation of synechiae between the ostium
and the nasal septum [7], and granuloma formation within the
ostium [7] can cause postoperative nasolacrimal duct
obstruction. Thus, resolving these factors and overcoming anatomical
variations will improve the success rate of endonasal DCR.
The uncinate process is a thin bony layer that extends
from the anterior end of the middle meatus, and spreads
downwards and backwards above the upper aspect of the
maxillary sinus [5]. The anterior part of the uncinate process
faces the lacrimal bone. McDonogh and Meiring [11]
suggested the potential use of the uncinate process as a
landmark in endonasal dacryocystorhinostomy.
In our research we have experienced favorable results
and prognosis in the treatment of patients with nasolacrimal
duct obstruction, using endonasal DCR with
unciformectomy. Here, we evaluated the anatomical advantages of the
uncinate process as a landmark, and studied the effect of
unciformectomy on the success rate and complications of
endonasal DCR. We suggest other contributing factors that
may improve the success rate in comparison with our
previous study.
Materials and methods
In total, 265 adult patients with symptomatic nasolacrimal duct
obstruction underwent endonasal DCR between January 2003
and February 2010. Patients were followed for longer than
6 months. In total, 288 eyes were included in the study; both
eyes in 23 patients and a single eye in 242 patients. The eyes
were classified into two groups according to whether
unciformectomy was performed or not (group A : endonasal DCR
with unciformectomy, group B : endonasal DCR alone). The
success rate and complications of the both groups were studied.
Nasolacrimal duct obstruction was confirmed prior to the
operation by positive probing (bone contact) and negative
irrigation. Dacryocystography was performed in some
cases, by injection of contrast (Ultravist injection 370,
Bayer, Germany) into the lacrimal canaliculi and lacrimal
sac to show the blocked or constricted location of
nasolacrimal pathway. Nasal cavity abnormalities were not
considered in assessing the result of our endonasal DCR
with unciformectomy.
All surgical procedures and surgical indications were the
same except unciformectomy and endonasal DCR was
performed by one surgeon. Patients underwent general
anesthesia, and gauze soaked with 1 % lidocaine and 1:1000
epinephrine mixed solution was packed into the nasal cavity
to decongest the nasal mucosa after anesthesia. The upper
and lower punctum were dilated. The 20-gauge vitrectomy
light source tip was inserted into the lower punctum and
reached the lacrimal sac. After identifying the location of the
lacrimal sac by transillumination, local anesthetic was
injected into the nasal mucosa of the transilluminated areas
around the uncinate process. In some patients, procedures
including middle turbinectomy, fracturing techniques of
septal cartilage by pushing the septum and the removal of
nasal polyps were performed to enlarge the nasal cavity. The
mucosa on the anterior part of the uncinate process was
removed via the anterior, through the insertion of the middle
turbinate using a Freer elevator. The lacrimal bone was
exposed after resection of the anterior of the uncinate
process. Nasal mucosa and lacrimal bone were removed, and
the ostium was increased in size to >8 mm diameter (...truncated)